Medikaloka Hermina PT (HEAL) — Capital Reinvestment Ratio
Medikaloka Hermina PT (HEAL) has a Capital Reinvestment Ratio of 1.96x as of June 2025, meaning it reinvests 2% of its operating cash flow (Rp225.37 Billion) in capital expenditures (Rp442.71 Billion). Check HEAL tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Medikaloka Hermina PT Capital Reinvestment Ratio (2015–2024)
This chart tracks Medikaloka Hermina PT's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see HEAL cash generation efficiency.
Annual Capital Reinvestment Ratio for Medikaloka Hermina PT (2015–2024)
Year-by-year Capital Reinvestment Ratio for Medikaloka Hermina PT from 2015 to 2024. See Medikaloka Hermina PT (HEAL) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (IDR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 2.01x | Rp1.14 Trillion | Rp2.28 Trillion | ▲ +66.3% |
| 2023 | 1.21x | Rp1.32 Trillion | Rp1.59 Trillion | ▼ -46.2% |
| 2022 | 2.24x | Rp503.58 Billion | Rp1.13 Trillion | ▲ +242.9% |
| 2021 | 0.65x | Rp1.86 Trillion | Rp1.21 Trillion | ▼ -17.2% |
| 2020 | 0.79x | Rp1.13 Trillion | Rp889.65 Billion | ▼ -21.5% |
| 2019 | 1.01x | Rp572.58 Billion | Rp575.94 Billion | ▼ -68.2% |
| 2018 | 3.16x | Rp241.67 Billion | Rp764.16 Billion | ▲ +111.2% |
| 2017 | 1.50x | Rp465.08 Billion | Rp696.31 Billion | ▲ +11.3% |
| 2016 | 1.34x | Rp362.85 Billion | Rp487.92 Billion | ▼ -24.0% |
| 2015 | 1.77x | Rp255.71 Billion | Rp452.66 Billion | — |